SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193805-20-000400
Filing Date
2020-03-25
Accepted
2020-03-25 10:17:05
Documents
1
Group Members
DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT III, L.P.DEERFIELD PRIVATE DESIGN FUND III, L.P.

Document Format Files

Seq Description Document Type Size
1 e619499_sc13g-lumos.htm SC 13G 101292
  Complete submission text file 0001193805-20-000400.txt   102594
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G

Mailing Address 515 CONGRESS AVENUE, SUITE 1800 AUSTIN TX 78701
Business Address 515 CONGRESS AVENUE, SUITE 1800 AUSTIN TX 78701 15124220155
Lumos Pharma, Inc. (Subject) CIK: 0001596584 (see all company filings)

IRS No.: 383830503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91469 | Film No.: 20740342